BR112012000115A2 - composição compreendendo aminoácidos e/ou peptídeos bioativos e óleo marinho em uma emulsão óleo-em-água estável, e o uso da dita composição como uma composição funcional ou terapêutica - Google Patents
composição compreendendo aminoácidos e/ou peptídeos bioativos e óleo marinho em uma emulsão óleo-em-água estável, e o uso da dita composição como uma composição funcional ou terapêuticaInfo
- Publication number
- BR112012000115A2 BR112012000115A2 BR112012000115A BR112012000115A BR112012000115A2 BR 112012000115 A2 BR112012000115 A2 BR 112012000115A2 BR 112012000115 A BR112012000115 A BR 112012000115A BR 112012000115 A BR112012000115 A BR 112012000115A BR 112012000115 A2 BR112012000115 A2 BR 112012000115A2
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- oil
- peptides
- functional
- amino acids
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 3
- 150000001413 amino acids Chemical class 0.000 title 1
- 230000000975 bioactive effect Effects 0.000 title 1
- 239000007764 o/w emulsion Substances 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Marine Sciences & Fisheries (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Edible Oils And Fats (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20092564 | 2009-07-06 | ||
| NO20092564A NO333013B1 (no) | 2009-07-06 | 2009-07-06 | Sammensetning omfattende bioaktive aminosyrer eller derivater derav og marin olje i en stabil olje-i-vannemulsjon, og fremgangsmate for fremstilling av nevnte sammensetning. |
| PCT/NO2010/000271 WO2011005113A1 (en) | 2009-07-06 | 2010-07-06 | Composition comprising bioactive amino acids and/or peptides and marine oil in a stable oil-in-water emulsion, and the use of said composition as a functional or therapeutic composition |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR112012000115A2 true BR112012000115A2 (pt) | 2016-03-15 |
| BR112012000115B1 BR112012000115B1 (pt) | 2020-10-27 |
| BR112012000115B8 BR112012000115B8 (pt) | 2021-05-25 |
Family
ID=43429376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012000115A BR112012000115B8 (pt) | 2009-07-06 | 2010-07-06 | composição compreendendo aminoácidos e/ou peptídeos bioativos e óleo marinho em uma emulsão óleo-em-água estável, processo para a produção e seus usos |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20120148679A1 (pt) |
| EP (2) | EP3375436A1 (pt) |
| CN (1) | CN102711731B (pt) |
| AU (1) | AU2010269242B2 (pt) |
| BR (1) | BR112012000115B8 (pt) |
| CA (1) | CA2764792C (pt) |
| NO (1) | NO333013B1 (pt) |
| WO (1) | WO2011005113A1 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10052352B2 (en) | 2011-06-15 | 2018-08-21 | Stable Solutions Llc | Therapeutic application of parenteral krill oil |
| PT2720701T (pt) * | 2011-06-15 | 2017-10-23 | Stable Solutions Llc | Aplicação terapêutica de óleo de krill parentérico |
| WO2014025905A1 (en) * | 2012-08-07 | 2014-02-13 | Buck Institute For Research On Aging | Multi-component formulation for improving neurological function |
| JP6120529B2 (ja) * | 2012-11-12 | 2017-04-26 | 株式会社エムワイピー | 鶏用飼料及び鶏の飼育方法 |
| EP3016666B1 (en) * | 2013-06-13 | 2019-05-15 | Smartfish AS | A marine oil formulation comprising reservatrol or derivatives thereof for use in treating, delaying and/or preventing alzheimer's desease |
| US10130601B2 (en) * | 2013-06-27 | 2018-11-20 | Smartfish As | Use of a composition comprising fish oil and juice for the treatment of inflammation |
| EP3079485B2 (en) * | 2013-12-13 | 2022-03-30 | Société des Produits Nestlé S.A. | Use of a modified sweet whey and a modified sweet whey containing infant formula for promoting the postnatal development of the infant central nervous system and related cognitive functions |
| NO20160913A1 (en) * | 2016-05-27 | 2017-11-28 | Smartfish As | Use of a composition comprising marine oil and juice for improving muscle performance. |
| CN107494762A (zh) * | 2017-08-24 | 2017-12-22 | 兰溪市捷喜食品加工技术有限公司 | 具有良好风味释放性的人造奶油及其制备方法 |
| CN108208838A (zh) * | 2018-03-09 | 2018-06-29 | 北京素维生物科技有限公司 | 一种掩味组合物及其用途 |
| US11191289B2 (en) | 2018-04-30 | 2021-12-07 | Kraft Foods Group Brands Llc | Spoonable smoothie and methods of production thereof |
| WO2021242044A1 (ko) * | 2020-05-28 | 2021-12-02 | 포항공과대학교 산학협력단 | 히비스커스, 로즈마리, 및 포도씨 추출물을 유효성분으로 포함하는 퇴행성 뇌질환의 예방 또는 치료 조성물 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61500432A (ja) * | 1982-12-09 | 1986-03-13 | ビルトン，ジエラルド エル． | 易吸収性脂肪酸エマルシヨン |
| US6451341B1 (en) * | 1990-02-05 | 2002-09-17 | Thomas J. Slaga | Time release formulation of vitamins, minerals and other beneficial supplements |
| SE9101642D0 (sv) | 1991-05-30 | 1991-05-30 | Kabi Pharmacia Ab | Phospholipids |
| US5514670A (en) * | 1993-08-13 | 1996-05-07 | Pharmos Corporation | Submicron emulsions for delivery of peptides |
| SE518823C2 (sv) | 1994-07-12 | 2002-11-26 | Karlshamns Lipidteknik Ab | Olja-i-vatten-emulsioner |
| US6440464B1 (en) | 1996-06-10 | 2002-08-27 | Viva Life Science | Nutritive composition for cardiovascular health containing fish oil, garlic, rutin, capsaicin, selenium, vitamins and juice concentrates |
| US7504376B2 (en) * | 1996-08-12 | 2009-03-17 | Natural Alternatives International | Methods and compositions for increasing the anaerobic working capacity in tissues |
| CA2376870C (en) * | 1999-06-25 | 2009-11-24 | Academisch Ziekenhuis Bij De Universiteit Van Amsterdam | Method for scavenging radicals with urocanic acid, derivatives and analogues |
| JP2001078702A (ja) * | 1999-07-12 | 2001-03-27 | Nippon Suisan Kaisha Ltd | まろやかさ、後味、うま味が増強された調味料 |
| JP3121331B1 (ja) | 1999-09-13 | 2000-12-25 | オーケー食品工業株式会社 | 惣菜の味付方法 |
| GB9925709D0 (en) * | 1999-10-30 | 1999-12-29 | Smithkline Beecham Plc | Composition |
| NO313076B1 (no) | 1999-12-28 | 2002-08-12 | Pronova Biocare As | Flytende n¶rings- og/eller nytelsesmiddel og fremgangsmåte for fremstilling derav |
| NO312371B1 (no) * | 2000-07-18 | 2002-04-29 | Norsk Hydro As | Fremgangsmåte ved stabilisering av umettede oljer |
| FR2820213B1 (fr) | 2001-01-31 | 2004-10-22 | Schlumberger Systems & Service | Dispositif d'alimentation electrique pour une installation de tests de composants |
| US20050209183A1 (en) * | 2002-07-25 | 2005-09-22 | Phenion Gmbh & Co. Kg | Cosmetic or pharmaceutical preparations comprising nucleic acids based on non-methylated CPG motifs |
| WO2004020977A2 (en) * | 2002-08-29 | 2004-03-11 | University Of Massachusetts | Utilization of emulsion interface engineering to produce oxidatively stable lipid delivery systems |
| US20040087490A1 (en) * | 2002-09-20 | 2004-05-06 | Troup John P. | Nutritional compositions |
| US20040219188A1 (en) * | 2003-05-02 | 2004-11-04 | Comer Gail M. | Composition and methods for nutritional management of patients with hepatic disease |
| GB0314624D0 (en) * | 2003-06-23 | 2003-07-30 | Advanced Bionutrition Europ Lt | Inflammatory disease treatment |
| US8628690B2 (en) * | 2004-02-23 | 2014-01-14 | The Texas A&M University System | Nanoemulsion compositions and methods of use thereof |
| CA2573854A1 (en) * | 2004-07-13 | 2006-02-16 | Rutgers, The State University Of New Jersey | Omega fatty acid fortified food products and methods for preparing same |
| NO322041B1 (no) | 2004-10-22 | 2006-08-07 | Pharmalogica As | Naeringsmiddelsupplement inneholdende fiskeolje og melkefaststoff som emulgator og fremgangsmate for fremstilling. |
| NO323665B1 (no) | 2005-06-27 | 2007-06-18 | Pharmalogica As | Drikk omfattende fiskeolje og probiotiske bakterier og fremgangsmate for fremstilling. |
| NO324262B1 (no) | 2005-11-29 | 2007-09-17 | Pharmalogica As | Bruksklar sammensetning omfattende fiskeolje og juice og fremstilling av denne, samt en forseglet beholder. |
| NO327925B1 (no) | 2007-06-25 | 2009-10-19 | Pharmalogica As | Anvendelse av kullsyre i drikker omfattende polyumettede fettsyrer (PUFA) for a hindre oksidasjon av fettsyrene. |
| HUP0700552A2 (en) | 2007-08-27 | 2009-03-30 | Janos Dr Feher | Method and composition inhibiting inflammation |
-
2009
- 2009-07-06 NO NO20092564A patent/NO333013B1/no not_active IP Right Cessation
-
2010
- 2010-07-06 CN CN201080030128.2A patent/CN102711731B/zh active Active
- 2010-07-06 BR BR112012000115A patent/BR112012000115B8/pt active IP Right Grant
- 2010-07-06 US US13/377,869 patent/US20120148679A1/en not_active Abandoned
- 2010-07-06 AU AU2010269242A patent/AU2010269242B2/en active Active
- 2010-07-06 WO PCT/NO2010/000271 patent/WO2011005113A1/en active Application Filing
- 2010-07-06 EP EP18170573.2A patent/EP3375436A1/en not_active Withdrawn
- 2010-07-06 CA CA2764792A patent/CA2764792C/en not_active Expired - Fee Related
- 2010-07-06 EP EP10797351.3A patent/EP2451439A4/en not_active Ceased
-
2014
- 2014-03-13 US US14/208,716 patent/US10105401B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2451439A1 (en) | 2012-05-16 |
| EP3375436A1 (en) | 2018-09-19 |
| BR112012000115B8 (pt) | 2021-05-25 |
| CN102711731A (zh) | 2012-10-03 |
| US20120148679A1 (en) | 2012-06-14 |
| CN102711731B (zh) | 2015-02-18 |
| CA2764792C (en) | 2019-01-15 |
| BR112012000115B1 (pt) | 2020-10-27 |
| CA2764792A1 (en) | 2011-01-13 |
| US20140287054A1 (en) | 2014-09-25 |
| NO333013B1 (no) | 2013-02-18 |
| NO20092564A1 (no) | 2011-01-07 |
| EP2451439A4 (en) | 2013-09-11 |
| WO2011005113A1 (en) | 2011-01-13 |
| AU2010269242B2 (en) | 2014-05-22 |
| AU2010269242A1 (en) | 2012-01-19 |
| US10105401B2 (en) | 2018-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012000115A2 (pt) | composição compreendendo aminoácidos e/ou peptídeos bioativos e óleo marinho em uma emulsão óleo-em-água estável, e o uso da dita composição como uma composição funcional ou terapêutica | |
| ES2330291B1 (es) | Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas. | |
| BRPI0719732A2 (pt) | nanopartículas de peptídeo e usos para as mesmas | |
| CL2012003026A1 (es) | Composicion farmaceutica que comprende pioglitazona y linagliptina; procedimiento de preparacion; uso en el tratamiento de la diabetes tipo 2 o la obesidad. | |
| CL2014001994A1 (es) | Polipeptido mimético de apelina sintéticos para el tratamiento e insuficiencia cardiaca; composicion farmacéutica que comprende dicho polipeptido. | |
| BR112015002933A2 (pt) | dispositivo implantável para uso no corpo humano e/ou animal para substituir uma válvula de um órgão. | |
| CL2009001424A1 (es) | Peptido tipo glucagon; dimero que comprende dos de dichos peptidos; composicion farmaceutica que lo comprende; y su uso para tratar diabetes o inducir perdida de peso. | |
| BRPI0916515A2 (pt) | polipeptídeo de g-csf bovinos modificados e usos dos mesmos | |
| DK2240595T4 (da) | Glykosyleret proteinekspression i prokaryoter | |
| BRPI0918139A2 (pt) | composição, alimento medicinal ou funcional, suplemento alimentar ou dietético para tratamento de distúrbios de desenvolvimento pervasivos com terapêuticos redox-ativos e uso | |
| CL2013000058A1 (es) | Uso de factor de polipeptidos ix para controlar o prevenir el sangrado en hemorragias menores, hemartrosis, hemorragia de musculo superficial, entre otras. | |
| BRPI0910702A2 (pt) | polipeptídeos de fator ix modificados e usos dos mesmos | |
| CL2014000801A1 (es) | Variante de factor 21 de crecimiento de fibroblasto humano (fgf21); composicion farmaceutica que lo comprende; y su uso para tratar diabetes tipo 2, obesidad, dislipidemia, sindrome metabolico o cualquier combinacion de los mismos. | |
| HK1200489A1 (en) | Recombinant human naglu protein and uses thereof naglu | |
| DK2252258T3 (da) | Anvendelse af naturlige aktive stoffer i kosmetiske eller terapeutiske sammensætninger | |
| BRPI0815836A2 (pt) | Construção de antígeno-vetor de fluorocarboneto, vetor de fluorocarboneto, composição farmacêutica, uso da construção, e, métodos de tratamento ou imunização, para estimular uma resposta imune, e para preparar uma resposta farmacêutica profilática ou terapêutica. | |
| BRPI0922790A2 (pt) | peptídeos de ligação sparc e usos dos mesmos | |
| HK1134246A1 (en) | Oil-in-water emulsified milky skin cosmetic preparation | |
| IL207144A0 (en) | Composition comprising protein and disperse fat | |
| FR2961814B1 (fr) | Nouveaux peptides activateurs de la sirtuine 6 et composition cosmetique ou pharmaceutiques les comprenant. | |
| CL2013001833A1 (es) | Composicion inmunomoduladora que comprende un vehiculo de administracion de liposoma cationico y una molecula de acido nucleico; y su uso para tratar una enfermedad respiratoria bovina en el ganado. | |
| BR112012003800A2 (pt) | composição, peptídeo, e formulação farmacêutica. | |
| BR112013014189A2 (pt) | composição farmacêutica que compreende transcinamaldeíco e o uso da mesma no tratamento de infecções | |
| BRPI0911945A2 (pt) | cc10 humana recombinante e suas composições para uso no tratamento de rinite nasal | |
| BRPI0916043A2 (pt) | composição farmacêutica e alimento funcional para prevenir ou tratar câncer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 35/60 (2006.01), A23L 2/52 (2006.01), A23L 2/ |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/10/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/07/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |